In This Issue:
- Case Analysis
..Prokaryotic Nucleic Acid Sequences
..Short Segments of Eukaryotic DNA
..Regulatory RNA sequences
..Genetically modified organisms
..New or Presently Pending Applications
- For More Information
- Excerpt from Summary:
On Thursday, June 13, 2013, the Supreme Court held that a patent claim directed to “an isolated DNA molecule” was not patent eligible under 35 U.S.C. §101 solely because the DNA molecule had been “isolated” from the rest of the genome. The Court found, however, that a cDNA (complementary DNA) molecule may be patent eligible, because a cDNA molecule is “not found in nature.” This conclusion assumes that a cDNA molecule is different from the genomic sequence because it lacks intron sequences.
Please see full Newsletter below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.